Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CETP | P11597 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7746748 | 0.76 | ALDH1A1 (0.32) | ALDH1A1HSD17B10 | |
| SCHEMBL18306044 | 0.76 | — | — | |
| SCHEMBL12364122 | 0.76 | — | — | |
| SCHEMBL18305963 | 0.76 | — | — | |
| SCHEMBL18351724 | 0.74 | — | — | |
| SCHEMBL28765168 | 0.73 | — | — | |
| Hydrochloric Acid SCHEMBL20531828 | 0.73 | — | — | |
| Hydrochloric Acid SCHEMBL20531826 | 0.73 | — | — | |
| SCHEMBL13112936 | 0.71 | — | — | |
| SCHEMBL14972912 | 0.70 | CETP (0.32) | CETPALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 237 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250161911-A1 | POLYMERS FOR THE REMOVAL OF PFAS FROM AQUEOUS COMPOSITIONS, AND METHODS OF MAKING AND USING THE SAME | GULF COAST ENVIRONMENTAL SYSTEMS LLC (DBA CONIFER SYSTEMS) | 2025-05-22 | — | — | US | claimed |
| WO-2025106778-A1 | POLYMERS FOR THE REMOVAL OF PFAS FROM AQUEOUS COMPOSITIONS, AND METHODS OF MAKING AND USING THE SAME | LUTUM TECHNOLOGY, LLC (US) | 2025-05-22 | — | — | WO | claimed |
| CN-113861688-B | Low-dielectric polyphenylene sulfide composite material and preparation method thereof | 江西聚真科技发展有限公司 | 2022-09-16 | — | — | CN | claimed |
| WO-2022191429-A1 | METHOD FOR ETCHING MULTI-LAMINATE OF SILICON-CONTAINING FILMS, AND METHOD FOR MANUFACTURING SEMICONDUCTOR DEVICE, COMPRISING SAME | 에스케이 머티리얼즈 주식회사 | 2022-09-15 | — | — | WO | claimed |
| CN-113861688-A | Low-dielectric polyphenylene sulfide composite material and preparation method thereof | 江西聚真科技发展有限公司 | 2021-12-31 | — | — | CN | claimed |
| US-9879293-B2 | Enzymatic transamination of cyclopamine analogs | INFINITY PHARMACEUTICALS, INC. (US) | 2018-01-30 | — | — | US | claimed |
| US-20160177354-A1 | ENZYMATIC TRANSAMINATION OF CYCLOPAMINE ANALOGS | SAFC, INC. | 2016-06-23 | — | — | US | claimed |
| EP-2462115-B1 | ENZYMATIC TRANSAMINATION OF CYCLOPAMINE ANALOGS | INFINITY PHARMACEUTICALS INC (US) | 2016-01-06 | — | — | EP | claimed |
| US-8703448-B2 | Enzymatic transamination of cyclopamine analogs | INFINITY PHARMACEUTICALS, INC. (US) | 2014-04-22 | — | — | US | claimed |
| EP-2462115-A1 | ENZYMATIC TRANSAMINATION OF CYCLOPAMINE ANALOGS | Infinity Pharmaceuticals, Inc. (US) | 2012-06-13 | — | — | EP | claimed |
| US-20120083607-A1 | Enzymatic Transamination of Cyclopamine Analogs | INFINITY PHARMACEUTICALS, INC. (US) | 2012-04-05 | — | — | US | claimed |
| WO-2011017551-A1 | ENZYMATIC TRANSAMINATION OF CYCLOPAMINE ANALOGS | INFINITY PHARMACEUTICALS, INC. (US) | 2011-02-10 | — | — | WO | claimed |
| US-20030050330-A1 | 4,5-subtstituted imdazolyl compounds for the treatment of inflammation | G.D. SEARLE & CO. | 2003-03-13 | — | — | US | claimed |
| EP-0772601-A1 | 4,5-SUBSTITUTED IMIDAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1997-05-14 | — | — | EP | claimed |
| WO-2025106778-A1 | POLYMERS FOR THE REMOVAL OF PFAS FROM AQUEOUS COMPOSITIONS, AND METHODS OF MAKING AND USING THE SAME | LUTUM TECHNOLOGY, LLC (US) | 2025-05-22 | — | — | WO | disclosed |
| US-20250161911-A1 | POLYMERS FOR THE REMOVAL OF PFAS FROM AQUEOUS COMPOSITIONS, AND METHODS OF MAKING AND USING THE SAME | GULF COAST ENVIRONMENTAL SYSTEMS LLC (DBA CONIFER SYSTEMS) | 2025-05-22 | — | — | US | disclosed |
| EP-4541422-A2 | QUINOLINE DERIVATIVES AS ALPHA4BETA7 INTEGRIN INHIBITORS | Gilead Sciences, Inc. (US) | 2025-04-23 | — | — | EP | disclosed |
| EP-0155423-A2 | Heat pumps | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1985-09-25 | — | — | EP | disclosed |
| US-4541943-A | FLUOROCARBON, FLUOROCARBON ETHER OR FLUOROALKYLAMINE FLUIDS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1985-09-17 | — | — | US | disclosed |
| EP-0127365-A2 | Heat pumps | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1984-12-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030050330-A1 | 4,5-subtstituted imdazolyl compounds for the treatment of inflammation | AHR, HACL2, IRAK2 | CETP 2555/4885ALDH1A1 112/4885HSD17B10 184/4885 |
| US-20120083607-A1 | Enzymatic Transamination of Cyclopamine Analogs | TKT, TALDO1, BCHE | CETP 1037/4885ALDH1A1 693/4885HSD17B10 305/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.